Navigation Links
Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
Date:9/17/2009

BASKING RIDGE, N.J., Sept. 17 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual property estate.

"We are very pleased with the EPO's decision to grant claims from a patent we believe will be fundamental to the development of active control agents for therapeutic aptamers," said David J. Mazzo, Ph.D., President and Chief Executive Officer of Regado Biosciences, Inc. "This patent is key to the protection of the Company's lead product candidate, the REG1 anticoagulation system, and its grant enables the exclusive use of modulator technology in this field solely by Regado."

The allowed claims in EP1401853 broadly cover oligonucleotide modulators that hybridize under physiological conditions to a blood coagulation factor aptamer, and, in so doing, specifically and rapidly reverse the anticoagulant and antithrombotic effects of the aptamer. Upon completion of certain formalities, the patent should issue in approximately six months. Regado also controls certain U.S. patent applications and issued patents covering aspects of the REG1 system, including patents covering certain RNA aptamers to coagulation factors (e.g. US7,312,325) and aptamer modulation (e.g. US7,300,922) exclusively licensed from Duke University, as well as improved coagulation factor modulator systems (e.g., US7,304,041) owned by the Company.

ABOUT REGADO BIOSCIENCES

Regado Biosciences is pioneering a new therapeutic technology with the creation and development of two-component drug syste
'/>"/>

SOURCE Regado Biosciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17, 2009
2. Regado Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2009 on September 11, 2009
3. Regado Biosciences to Present at the Rodman & Renshaw Global Investment Conference on September 10, 2009
4. Regado Biosciences Announces First Patient Enrolled In Phase 1 Study Of Subcutaneously Administered Reg1 Anticoagulation System
5. Regado Biosciences Expands Medical Advisory Board
6. Regado Biosciences Establishes Medical Advisory Board
7. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
8. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
9. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
10. Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
11. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 The Pittcon Organizing Committee ... Food Safety Tech , an e-Journal and producer of ... agreement for the second year for the co-location of Food ... The partnership provides that the registration fee to attend the ...
(Date:1/15/2014)... California , January 15, 2014 Oxford ... today announced the appointment of Thomas C Reynolds MD, PhD ... years, development experience gained in the biotechnology industry, most recently ... am delighted to welcome Tom at this transformative time for ...
(Date:1/15/2014)... 15, 2014 More than 5 million ... 1 in 3 seniors will die with Alzheimer’s or ... jaw-dropping figures have shocked many Americans into looking for ... prevent these tragic age-related cognitive disorders. Jonathan Weisman, president ...
(Date:1/15/2014)... 2013 was a banner year of continued innovation ... continued independent research led by the team at Wake ... million grant from the Susanne Marcus Collins Foundation, had ... reviewed journal, Amy Grant highlighted Brainwave Optimization® in First ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... , , OMAHA, Neb., Aug. 12 Transgenomic Inc. (OTC Bulletin ... Transgenomic Inc. Second Quarter 2009 Earnings Release, ... Wednesday, August 12, 2009 @ 5:00 p.m. Eastern, Where: http://www.transgenomic.com/events.asp?id=6 , ... to the web at the, ...
... , SAN DIEGO, Aug. 12 Imagenetix, ... second study conducted on its proprietary compound, 1-TDC, for the treatment ... University, Department of Periodontology and Oral Biology, led the investigative team. ... of Periodontology and is also available online at: ...
... ATLANTA, Aug. 12 CryoLife, Inc., (NYSE: ... cardiovascular tissue processing company, today announced that it has ... Administration (FDA) for its CryoPatch((R)) SG pulmonary human cardiac ... SynerGraft technology designed to remove allogeneic donor cells and ...
Cached Biology Technology:Reminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast 2Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology 2Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology 3CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Cardiac Patch Material 2CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Cardiac Patch Material 3CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Cardiac Patch Material 4
(Date:4/18/2014)... Ill. For the past 20 years, researchers have ... the research findings have suggested that soil organic carbon ... conventional tillage systems to no-till systems. However, there is ... systems in corn and soybean rotations without cover crops, ... organic carbon stocks at the published rates. , "Some ...
(Date:4/18/2014)... University] Asteroid and comet impacts can cause widespread ... or even global scales. But new research from Brown ... of ancient life at the time of an impact. ... Schultz has found fragments of leaves and preserved organic ... impacts in Argentina. The material could provide a snapshot ...
(Date:4/17/2014)... drug under clinical trials to treat tuberculosis could be ... act against various bacteria, fungal infections and parasites, yet ... Illinois chemists and collaborators. , Led by U. of ... different ways the drug SQ109 attacks the tuberculosis bacterium, ... pathogens from yeast to malaria and how targeting ...
Breaking Biology News(10 mins):Researchers question published no-till soil organic carbon sequestration rates 2Researchers question published no-till soil organic carbon sequestration rates 3Researchers question published no-till soil organic carbon sequestration rates 4Impact glass stores biodata for millions of years 2Impact glass stores biodata for millions of years 3Multitarget TB drug could treat other diseases, evade resistance 2
... In the waters along Florida,s east and west coasts, ... on the once severely overfished Atlantic goliath grouper, a ... southeastern United States after a 21-year moratorium on its ... world. The three-year study will determine what specific ...
... A new research program funded by the National ... changing climate has on human health. Led by NIH,s ... will research the risk factors that make people more ... environmental exposures, such as air pollution and toxic chemicals; ...
... iPhone app that measures the user,s heart rate is not ... idea for a Worcester Polytechnic Institute (WPI) researcher who is ... medical monitors able to capture and transmit vital physiological data. ... of biomedical engineering at WPI, has developed a smart phone ...
Cached Biology News:FSU biologists fish for reasons behind endangered grouper's comeback 2FSU biologists fish for reasons behind endangered grouper's comeback 3NIH launches research program to explore health effects from climate change 2NIH launches research program to explore health effects from climate change 3Hold the phone for vital signs 2
... Advance 9.1 is the ... integrated application for desktop ... biology data management available. ... for export. Robust on-board ...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
... Engineered with new technology incorporating ... for unsurpassed flexibility, the new Varian ... advanced spectrometer available today., ,The Varian ... each transmitter and receiver channel, providing ...
Biology Products: